# A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

> **NCT00867009** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 113 (actual)

## Conditions studied

- Non-Small-Cell Lung Cancer

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Cisplatin
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00867009
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-05
- **Final completion:** 2014-09
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2015-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867009, "A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00867009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*